Synonym
Thalicarpine; taliblastine; thaliblastin; thalicarpin.
IUPAC/Chemical Name
(S)-9-(2-(((S)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)-4,5-dimethoxyphenoxy)-1,2,10-trimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline
InChi Key
ZCTJIMXXSXQXRI-KYJUHHDHSA-N
InChi Code
InChI=1S/C41H48N2O8/c1-42-12-10-23-16-32(44-3)34(46-5)20-27(23)29(42)15-26-19-33(45-4)36(48-7)22-31(26)51-37-18-25-14-30-39-24(11-13-43(30)2)17-38(49-8)41(50-9)40(39)28(25)21-35(37)47-6/h16-22,29-30H,10-15H2,1-9H3/t29-,30-/m0/s1
SMILES Code
CN1CCC2=CC(OC)=C(OC)C3=C2[C@]1([H])CC4=CC(OC5=CC(OC)=C(OC)C=C5C[C@@H]6N(C)CCC7=C6C=C(OC)C(OC)=C7)=C(OC)C=C34
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO, not in water
Shelf Life
>5 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
696.83
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Wu WN, McKown LA. The in vitro metabolism of thalicarpine, an aporphine-benzyltetrahydroisoquinoline alkaloid, in the rat. API-MS/MS identification of thalicarpine and metabolites. J Pharm Biomed Anal. 2002 Aug 22;30(1):141-50. PubMed PMID: 12151074.
2: Leimert JT, Corder MP, Elliott TE, Lovett JM. An abbreviated phase II trial of thalicarpine. Cancer Treat Rep. 1980;64(12):1389-90. PubMed PMID: 6451289.
3: Kupchan SM, Dhingra OP, Ramachandran V, Kim CK. Proaporphine--aporphine dimers and a bisaporphine derived from the tumor-inhibitory alkaloid thalicarpine. J Org Chem. 1978 Jan 6;43(1):105-8. PubMed PMID: 145476.
4: Nabih T, Davis PJ, Caputo JF, Rosazza JP. Microbial transformations of natural antitumor agents. 3. Conversion of thalicarpine to (+)-hernandalinol by Streptomyces punipalus. J Med Chem. 1977 Jul;20(7):914-7. PubMed PMID: 141523.
5: Creasey WA. Biochemical effects of d-tetrandrine and thalicarpine. Biochem Pharmacol. 1976 Aug 15;25(16):1887-91. PubMed PMID: 134714.
6: Creaven PJ, Allen LM. Thalicarpine (NSC-68075): plasma decay and urinary excretion in man. Cancer Treat Rep. 1976 Jan;60(1):69-75. PubMed PMID: 137078.
7: Creaven PJ, Cohen MH, Selawry OS, Tejada F, Broder LE. Phase I study of thalicarpine (NAC-68075), a plant alkaloid of noval structure. Cancer Chemother Rep. 1975 Sep-Oct;59(5):1001-6. PubMed PMID: 128411.
8: Creaven PJ, Allen LM, Williams CP. The interaction of the antineoplastic drug thalicarpine with aniline hydroxylase and microsomal cytochrome of rat liver. Xenobiotica. 1974 Apr;4(4):255-61. PubMed PMID: 4152572.
9: Allen LM, Creaven PJ. Binding of a new antitumor agent, thalicarpine, to DNA. J Pharm Sci. 1974 Mar;63(3):474-5. PubMed PMID: 4856551.
10: Allen LM, Creaven PJ. Inhibition of macromolecular biosynthesis in cultured L1210 mouse leukemia cells by thalicarpine (NSC 68075). Cancer Res. 1973 Dec;33(12):3112-6. PubMed PMID: 4796799.
